Guzm&;#x00E1;n, M., Duarte, M. J., Blázquez, C., Ravina, J., Rosa, M. C., Galve-Roperh, I., . . . González-Feria, L. (2006). A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. British Journal of Cancer, 95(2), 197. https://doi.org/10.1038/sj.bjc.6603236
Chicago Style (17th ed.) CitationGuzm&;#x00E1;n, M., M. J. Duarte, C. Blázquez, J. Ravina, M. C. Rosa, I. Galve-Roperh, C. Sánchez, G. Velasco, and L. González-Feria. "A Pilot Clinical Study of Δ9-tetrahydrocannabinol in Patients with Recurrent Glioblastoma Multiforme." British Journal of Cancer 95, no. 2 (2006): 197. https://doi.org/10.1038/sj.bjc.6603236.
MLA (9th ed.) CitationGuzm&;#x00E1;n, M., et al. "A Pilot Clinical Study of Δ9-tetrahydrocannabinol in Patients with Recurrent Glioblastoma Multiforme." British Journal of Cancer, vol. 95, no. 2, 2006, p. 197, https://doi.org/10.1038/sj.bjc.6603236.